The SF-86 is 136 pages of questions. How you answer the drug-use questions can shape your clearance outcome in ways that are often larger than the underlying conduct. Past drug use does not end a clearance case on its own. Omissions often do.
DCSA investigators are trained to find discrepancies. Credit checks, criminal history databases, interviews with references, and social media reviews can surface information that was not included. An omission that investigators discover during the background investigation becomes a Guideline E (Personal Conduct) integrity concern layered on top of the underlying Guideline H (drug involvement) concern. One issue becomes two.
Guideline E: candor often matters more than the conduct itself
What the SF-86 actually asks about drug use
Section 23 of the SF-86 (eQIP) covers drug use and related conduct. Most questions cover illegal drug use or involvement within the past seven (7) years, though some categories require disclosure for your entire lifetime. It also asks about drug-related criminal offenses, drug-related counseling and treatment, and whether you believe you are a current user. Each question has its own wording, and the framing matters. Read every question carefully and answer what is actually asked.
For marijuana specifically: if you used marijuana in a state where it was legal under state law, it was still illegal under federal law at the time. The SF-86 asks about use of illegal drugs, and the answer is measured against federal law, not state law. Disclose it.
How far back the drug use questions go
The SF-86 generally uses a 7-year lookback for drug use, though some questions extend your entire lifetime. Use beyond the lookback window may not need to be affirmatively disclosed in response to the standard questions, but a Subject Interview can raise questions about conduct outside the window when it is relevant to current security risk. For patterns of use that continued into the lookback window, the full pattern has to be disclosed, not just the most recent instance.
The Trusted Workforce 2.0 PVQ: what is changing
Under Trusted Workforce 2.0, the Personnel Security Questionnaire (PVQ) is being implemented as the next-generation replacement for the SF-86. The rollout is staged, and the SF-86 remains in use for many applicants. The PVQ streamlines some questions and integrates with Continuous Vetting, which means information flows continuously rather than in 5-year reinvestigation cycles. The underlying standards (SEAD 4, the 13 adjudicative guidelines) do not change. Drug-use disclosure still matters, candor still matters, and omissions still carry the same Guideline E risk. If your case is on the PVQ rather than the SF-86, the principles below still apply.
How to approach drug-use disclosure on the SF-86 (or PVQ)
- 1
Gather the facts before you start filling out the form
Know the timeline: when use started, how frequent it was, when it stopped. Approximate dates with context (for example, 'approximately 2018 to 2019, during college') are standard and acceptable when exact dates are not available. What is not acceptable is guessing in a direction that understates recency or frequency.
- 2
Answer every drug-related question, not just the ones that seem to apply
The SF-86 has multiple drug-related questions. Answer all of them. If a question asks whether you have ever been referred to counseling for drug use, and you have, answer accurately. Investigators contact employers, schools, and references.
- 3
Use the comments section for context
The form provides a comments section for each drug question. Use it. Explain what the use was (marijuana, prescription medication used outside of a prescription, and so on), the circumstances, and when it stopped. Adjudicators read these comments, and they can matter for mitigation.
- 4
Do not round favorable: disclose the accurate timeframe
If you stopped using marijuana 13 months before you filed the form, say 13 months. Do not round to 14 to move past the 12-month threshold. Investigators can cross-reference employment records, social media, and other sources. A minor rounding that is later contradicted can become a deliberate falsification finding.
- 5
Have an attorney review your disclosure before you submit
If you have drug use to disclose (especially recent use, use of substances other than marijuana, or use during military service or cleared employment), a paid SF-86 consultation with an attorney before you file is often worth it. A properly framed disclosure is part of the mitigation case.
136 pages
The length of the SF-86 blank form
The SF-86 is a 136-page background investigation questionnaire. Drug-use questions appear in Section 23 and related sections. Every answer carries weight, and the comments sections allow for context that adjudicators often weigh when evaluating mitigation.
Honesty vs. disclosure strategy: what adjudicators weigh
Accurate disclosure is the foundation. On top of accuracy, how the disclosure is framed matters. The same underlying fact (for example, recreational marijuana use two years ago, no use since) can be presented in a way that matches how adjudicators weigh it under Guideline H mitigating conditions. The comments section, the Subject Interview, and any supplemental materials should all reinforce the mitigation story: the use is remote, it has stopped, there are no other concerning indicators, and the applicant can be relied on to provide accurate information.
After you file, a DCSA investigator typically conducts a Subject Interview (or, in some cases, a written interrogatory) where you will be asked about the drug use you disclosed. Be consistent with the form. Discrepancies between what you wrote and what you say in the interview can become a credibility concern on their own.
“In drug disclosure cases, the data is clear. Accurate disclosure plus time often equals the best chance of approval. The candidates who get into trouble are the ones who try to minimize what they disclosed and then get caught in the gap between what they said and what the investigation found.”
What happens if you underreport on the SF-86
If you submitted an SF-86 and realize you omitted drug use that should have been disclosed, consult an attorney before the investigation concludes. In some circumstances, a proactive supplemental disclosure (submitted before the investigator surfaces the omission independently) can be presented as a voluntary correction rather than a deliberate falsification. Timing matters. Waiting until the investigator raises the issue is not the same as voluntarily coming forward.
Frequently asked questions about SF-86 drug disclosure
Take Action
Drug use on your SF-86? Get it right before you file.
SF-86 consultations are paid advice, not a free call. Matthew offers a paid 60-minute consultation specifically for applicants with drug use or other sensitive conduct to disclose. The hour can change how the form lands.
Book a Paid 60-Min Consultation
